We use cookies to understand how you use our site and to improve your experience.
This includes personalizing content and advertising.
By pressing "Accept All" or closing out of this banner, you consent to the use of all cookies and similar technologies and the sharing of information they collect with third parties.
You can reject marketing cookies by pressing "Deny Optional," but we still use essential, performance, and functional cookies.
In addition, whether you "Accept All," Deny Optional," click the X or otherwise continue to use the site, you accept our Privacy Policy and Terms of Service, revised from time to time.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
HealthEquity (HQY) Up 2.3% Since Last Earnings Report: Can It Continue?
Read MoreHide Full Article
A month has gone by since the last earnings report for HealthEquity (HQY - Free Report) . Shares have added about 2.3% in that time frame, outperforming the S&P 500.
Will the recent positive trend continue leading up to its next earnings release, or is HealthEquity due for a pullback? Before we dive into how investors and analysts have reacted as of late, let's take a quick look at the most recent earnings report in order to get a better handle on the important catalysts.
HealthEquity Q1 Earnings and Revenues Miss Estimates
HealthEquity, Inc. reported adjusted earnings per share of 43 cents in first-quarter fiscal 2021, which missed the Zacks Consensus Estimate of 44 cents by 2.3%. The bottom line was flat on a year-over-year basis.
Revenues in Detail
The company generated revenues of $190 million, missing the Zacks Consensus Estimate by 1.3%. However, the figure skyrocketed 118% from the prior-year quarter.
HSA Member Detail
As of Apr 30, 2020, the total number of Health Savings Accounts (HSA), for which HealthEquity served as a non-bank custodian (HSA members), was 5.4 million, up 33% year over year.
Additionally, total Active HSA assets were $11.5 billion, up 38% year over year.
Total Accounts, including HSAs and complementary CDB accounts, came in at 12.7 million, up 169% year over year.
Segmental Performance
Service Revenues: At this segment, revenues totaled $111.3 million, up 315.3% from the year-ago figure.
Custodial Revenues: At this segment, revenues grew 11.9% year over year to $46.9 million.
Interchange Revenues: At this segment, revenues soared 73.8% year over year to $31.8 million.
Margin Details
HealthEquity generated gross profit of $108.1 million, up 87.1% from the year-ago quarter. Gross margin was 56.9% of net revenues, down 947 bps year over year.
Adjusted operating profit in the fiscal first quarter was $46.5 million, up 59.6% year over year. Adjusted operating margin totaled 24.5% in the quarter, contracting 901 bps year over year.
Guidance
Due to uncertainty regarding the impact of the COVID-19 pandemic, the company is withdrawing its fiscal 2021 guidance.
For the fiscal second quarter, the company expects revenues between $168 million and $173 million. The Zacks Consensus Estimate for the same is pegged at $190.7 million.
Adjusted net income is projected between $17 million and $22 million.
Adjusted EPS is expected within 23-30 cents. The Zacks Consensus Estimate for earnings is pegged at 45 cents.
How Have Estimates Been Moving Since Then?
In the past month, investors have witnessed a downward trend in estimates revision. The consensus estimate has shifted -55.48% due to these changes.
VGM Scores
At this time, HealthEquity has an average Growth Score of C, a grade with the same score on the momentum front. However, the stock was allocated a grade of F on the value side, putting it in the lowest quintile for this investment strategy.
Overall, the stock has an aggregate VGM Score of D. If you aren't focused on one strategy, this score is the one you should be interested in.
Outlook
Estimates have been broadly trending downward for the stock, and the magnitude of these revisions indicates a downward shift. It's no surprise HealthEquity has a Zacks Rank #5 (Strong Sell). We expect a below average return from the stock in the next few months.
See More Zacks Research for These Tickers
Normally $25 each - click below to receive one report FREE:
Image: Bigstock
HealthEquity (HQY) Up 2.3% Since Last Earnings Report: Can It Continue?
A month has gone by since the last earnings report for HealthEquity (HQY - Free Report) . Shares have added about 2.3% in that time frame, outperforming the S&P 500.
Will the recent positive trend continue leading up to its next earnings release, or is HealthEquity due for a pullback? Before we dive into how investors and analysts have reacted as of late, let's take a quick look at the most recent earnings report in order to get a better handle on the important catalysts.
HealthEquity Q1 Earnings and Revenues Miss Estimates
HealthEquity, Inc. reported adjusted earnings per share of 43 cents in first-quarter fiscal 2021, which missed the Zacks Consensus Estimate of 44 cents by 2.3%. The bottom line was flat on a year-over-year basis.
Revenues in Detail
The company generated revenues of $190 million, missing the Zacks Consensus Estimate by 1.3%. However, the figure skyrocketed 118% from the prior-year quarter.
HSA Member Detail
As of Apr 30, 2020, the total number of Health Savings Accounts (HSA), for which HealthEquity served as a non-bank custodian (HSA members), was 5.4 million, up 33% year over year.
Additionally, total Active HSA assets were $11.5 billion, up 38% year over year.
Total Accounts, including HSAs and complementary CDB accounts, came in at 12.7 million, up 169% year over year.
Segmental Performance
Service Revenues: At this segment, revenues totaled $111.3 million, up 315.3% from the year-ago figure.
Custodial Revenues: At this segment, revenues grew 11.9% year over year to $46.9 million.
Interchange Revenues: At this segment, revenues soared 73.8% year over year to $31.8 million.
Margin Details
HealthEquity generated gross profit of $108.1 million, up 87.1% from the year-ago quarter. Gross margin was 56.9% of net revenues, down 947 bps year over year.
Adjusted operating profit in the fiscal first quarter was $46.5 million, up 59.6% year over year. Adjusted operating margin totaled 24.5% in the quarter, contracting 901 bps year over year.
Guidance
Due to uncertainty regarding the impact of the COVID-19 pandemic, the company is withdrawing its fiscal 2021 guidance.
For the fiscal second quarter, the company expects revenues between $168 million and $173 million. The Zacks Consensus Estimate for the same is pegged at $190.7 million.
Adjusted net income is projected between $17 million and $22 million.
Adjusted EPS is expected within 23-30 cents. The Zacks Consensus Estimate for earnings is pegged at 45 cents.
How Have Estimates Been Moving Since Then?
In the past month, investors have witnessed a downward trend in estimates revision. The consensus estimate has shifted -55.48% due to these changes.
VGM Scores
At this time, HealthEquity has an average Growth Score of C, a grade with the same score on the momentum front. However, the stock was allocated a grade of F on the value side, putting it in the lowest quintile for this investment strategy.
Overall, the stock has an aggregate VGM Score of D. If you aren't focused on one strategy, this score is the one you should be interested in.
Outlook
Estimates have been broadly trending downward for the stock, and the magnitude of these revisions indicates a downward shift. It's no surprise HealthEquity has a Zacks Rank #5 (Strong Sell). We expect a below average return from the stock in the next few months.